These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28123366)

  • 1. Cerebral Blood Flow and Aβ-Amyloid Estimates by WARM Analysis of [
    Rodell AB; O'Keefe G; Rowe CC; Villemagne VL; Gjedde A
    Front Aging Neurosci; 2016; 8():321. PubMed ID: 28123366
    [No Abstract]   [Full Text] [Related]  

  • 2. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Chen Q; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Graff-Radford J; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Parisi JE; Dickson DW; Petersen RC; Boeve BF; Murray ME
    Neurology; 2020 Jan; 94(3):e282-e291. PubMed ID: 31862783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer's disease.
    Peretti DE; Vállez García D; Reesink FE; Doorduin J; de Jong BM; De Deyn PP; Dierckx RAJO; Boellaard R
    EJNMMI Res; 2019 Jul; 9(1):59. PubMed ID: 31273465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of [
    Li Y; Zhang X; Zhao H; Wang Y; Zhang D; Wang X; Dong R; Yan XX; Wu J; Sui Y; Zhang J; Cui M
    ACS Pharmacol Transl Sci; 2024 Jul; 7(7):2054-2062. PubMed ID: 39022359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A universal neocortical mask for Centiloid quantification.
    Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
    Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population.
    Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Mailick MR; Klunk WE; Johnson SC; Christian BT
    Alzheimers Dement (Amst); 2017; 9():1-9. PubMed ID: 28603769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.
    Yazdan-Panah A; Bodini B; Soulier T; Veronese M; Bottlaender M; Tonietto M; Stankoff B
    EJNMMI Res; 2024 May; 14(1):50. PubMed ID: 38801594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails.
    Rischel EB; Gejl M; Brock B; Rungby J; Gjedde A
    Alzheimers Dement; 2022 Jun; ():. PubMed ID: 35673950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.
    Laforce R; Rabinovici GD
    Alzheimers Res Ther; 2011 Nov; 3(6):31. PubMed ID: 22071129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
    Yamakuni R; Murakami T; Ukon N; Kakamu T; Toda W; Hattori K; Sekino H; Ishii S; Fukushima K; Matsuda H; Ugawa Y; Wakasugi N; Abe M; Ito H
    Ann Nucl Med; 2024 Jun; ():. PubMed ID: 38902587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Synaptic Loss in β-Amyloid Positive Versus β-Amyloid Negative Corticobasal Syndrome.
    Holland N; Savulich G; Jones PS; Whiteside DJ; Street D; Swann P; Naessens M; Malpetti M; Hong YT; Fryer TD; Rittman T; Mulroy E; Aigbirhio FI; Bhatia KP; O'Brien JT; Rowe JB
    Mov Disord; 2024 Apr; ():. PubMed ID: 38671545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Experience with Good Manufacturing Practice Production of [
    Andersen ABA; Lehel S; Grove EK; Langkjaer N; Fuglø D; Huynh THV
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring cerebral perfusion with [
    Mak E; Grigorova M; Beresford-Webb J; Malpetti M; Walpert M; Brown S; Jones E; Clare I; Hong YT; Fryer TD; Coles JP; Aigbirhio FI; Menon DK; Nestor PJ; Holland AJ; Zaman SH
    Brain Commun; 2021; 3(1):fcaa198. PubMed ID: 33543138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalised Carbon Nanotubes Enhance Brain Delivery of Amyloid-Targeting Pittsburgh Compound B (PiB)-Derived Ligands.
    Costa PM; Wang JT; Morfin JF; Khanum T; To W; Sosabowski J; Tóth E; Al-Jamal KT
    Nanotheranostics; 2018; 2(2):168-183. PubMed ID: 29577020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of cerebral vascular reactivity and resting blood flow in early-staged transgenic AD mice:
    Jeong H; Pan Y; Akhter F; Volkow ND; Zhu D; Du C
    Res Sq; 2023 Nov; ():. PubMed ID: 37987006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ComBat harmonization for reducing across-tracer biases in regional amyloid PET analyses.
    Yang B; Earnest T; Kumar S; Kothapalli D; Benzinger T; Gordon B; Sotiras A
    medRxiv; 2024 Jun; ():. PubMed ID: 38947044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect.
    Rodell AB; Aanerud J; Braendgaard H; Gjedde A
    Front Neuroenergetics; 2012; 4():8. PubMed ID: 22783187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two decades of [
    Myburgh PJ; Solingapuram Sai KK
    Am J Nucl Med Mol Imaging; 2024; 14(1):48-62. PubMed ID: 38500746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease.
    Ismail R; Hansen AK; Parbo P; Brændgaard H; Gottrup H; Brooks DJ; Borghammer P
    Int J Alzheimers Dis; 2018; 2018():6852303. PubMed ID: 30155285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.
    Okuyama C; Higashi T; Ishizu K; Oishi N; Kusano K; Ito M; Kagawa S; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Watanabe H; Ono M; Yamauchi H
    Ann Nucl Med; 2024 Jun; ():. PubMed ID: 38907835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.